A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma

Trial Profile

A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma

Completed
Phase of Trial: Phase I

Latest Information Update: 25 May 2016

At a glance

  • Drugs Cixutumumab (Primary) ; Doxorubicin
  • Indications Soft tissue sarcoma
  • Focus Adverse reactions
  • Most Recent Events

    • 16 May 2016 Status changed from active, no longer recruiting to completed.
    • 11 Mar 2013 Planned number of patients changed from 60 to 30 as reported by ClinicalTrials.gov.
    • 11 Mar 2013 Planned end date changed from 1 Dec 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top